680
Participants
Start Date
August 31, 2007
Primary Completion Date
November 30, 2007
Study Completion Date
November 30, 2007
fluticasone furoate, fexofenadine
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Orangeburg
GSK Investigational Site, Spartanburg
GSK Investigational Site, Charleston
GSK Investigational Site, Lawrenceville
GSK Investigational Site, Albany
GSK Investigational Site, Columbus
GSK Investigational Site, Knoxville
GSK Investigational Site, Jackson
GSK Investigational Site, Louisville
GSK Investigational Site, Owensboro
GSK Investigational Site, Sylvania
GSK Investigational Site, Canton
GSK Investigational Site, Cincinnati
GSK Investigational Site, Indianapolis
GSK Investigational Site, South Bend
GSK Investigational Site, Evansville
GSK Investigational Site, Lafayette
GSK Investigational Site, Ypsilanti
GSK Investigational Site, Novi
GSK Investigational Site, Iowa City
GSK Investigational Site, Milwaukee
GSK Investigational Site, West Allis
GSK Investigational Site, Greenfield
GSK Investigational Site, Minneapolis
GSK Investigational Site, Plymouth
GSK Investigational Site, Chicago
GSK Investigational Site, Normal
GSK Investigational Site, St Louis
GSK Investigational Site, St Louis
GSK Investigational Site, Warrensburg
GSK Investigational Site, Columbia
GSK Investigational Site, Rolla
GSK Investigational Site, Papillion
GSK Investigational Site, Omaha
GSK Investigational Site, Omaha
GSK Investigational Site, Lincoln
GSK Investigational Site, Metairie
GSK Investigational Site, Sunset
GSK Investigational Site, Little Rock
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Waco
Lead Sponsor
GlaxoSmithKline
INDUSTRY